Wanfu Lin

7PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersTraditional Chinese medicine and treatmentsHaematological tumoursMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Dihydrolipoamide dehydrogenase promotes hepatocellular carcinoma progression and modulates cuproptosis-dependent cell death.

|Jun 01, 2022
Corrigendum to "The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways".

Shufang Liang, Yong Zou, Jingdong Gao

|Jan 28, 2021
Effect and Molecular Mechanisms of Jiedu Recipe on Hypoxia-Induced Angiogenesis after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma.

Wanfu Lin, Huan Wang, Maofeng Zhong

|May 07, 2019
Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer.

Qunwei Chen, Wanfu Lin, Zifei Yin

|Mar 12, 2019
Identification of Traditional Chinese Medicine Constitutions and Physiological Indexes Risk Factors in Metabolic Syndrome: A Data Mining Approach.

Yanchao Tang, Tong Zhao, Nian Huang

|Sep 04, 2018
The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways.

Shufang Liang, Yong Zou, Jingdong Gao

Pageof 2

Frequent Collaborators

6 joint publications

Changquan Ling

5 joint publications

Binbin Cheng

4 joint publications

Juan Du

4 joint publications

Shufang Liang